Effects of antianginal agents on the coronary circulation.
D000787:Angina Pectoris / Q000188:drug therapy*; D000818:Animals; D001161:Arteriosclerosis / Q000503:physiopathology; D002118:Calcium / Q000037:antagonists & inhibitors; D003097:Collateral Circulation / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects*; D003331:Coronary Vessels / Q000502:physiology; D004285:Dogs; D006706:Homeostasis; D006801:Humans; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D009543:Nifedipine / Q000494:pharmacology; D005996:Nitroglycerin / Q000627:therapeutic use; D010477:Perfusion; D011433:Propranolol / Q000494:pharmacology; D014655:Vascular Resistance; D014700:Verapamil / Q000494:pharmacology
D011433:Propranolol; D014700:Verapamil; D005996:Nitroglycerin; D009543:Nifedipine; D002118:Calcium